FDA Adverse Event Malfunction Summary report: N

BD BACTEC¿ PLUS AEROBIC/F CULTURE VIALS (PLASTIC)

MDR report key: 21411957 · Received February 19, 2025

Report

Report Number
2647876-2025-00016
Event Type
Malfunction
Date Received
February 19, 2025
Date of Event
January 28, 2025
Report Date
April 1, 2025
Manufacturer
BECTON DICKINSON CARIBE LTD.
Product Code
MDB
UDI-DI
00382904420239
PMA / PMN Number
K113558
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NZ
Reporter Occupation
NURSE
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

G5: PMA/510(K)#: K222591) THE INFORMATION FOR THE ADDITIONAL 510K IS AS FOLLOWS: G4. PMA / 510(K)#: K222591. A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

INVESTIGATION SUMMARY - CATALOG: 442023, BATCH NO. 4319541. CUSTOMER REPORTED NO GROWTH WHILE USING BACTEC PRODUCT. NEITHER PHOTOS NOR RETURNED GOOD SAMPLES WERE RECEIVED. BD WAS UNABLE TO REPRODUCE CUSTOMER¿S EXPERIENCE WITH THE BACTEC PRODUCT. SATISFACTORY RESULTS WERE OBTAINED FROM RETENTION SAMPLES WHEN TESTED FOR MICROBIAL INSTRUMENT DETECTION. ALSO, GRAM STAIN WAS PERFORMED WITH SATISFACTORY RESULTS. A COMPLAINT HISTORY REVIEW WAS CONDUCTED AND ONLY THE CURRENT COMPLAINT WAS FOUND RELATING TO THE INCIDENT LOT NUMBER AND THE ¿AS REPORTED¿ DEFECT CODE. BATCH HISTORY RECORDS REVIEW DID NOT IDENTIFY ANY EVIDENCE FOR WHICH THE CUSTOMER SUBMITTED THE COMPLAINT. COMPLAINT IS UNCONFIRMED BASED ON RETENTION SAMPLES AND BATCH RECORD REVIEW RESULTS. QUALITY CONTROL CERTIFICATES LIST TEST ORGANISM, INCLUDING ATCC¿ CULTURE SPECIFIED IN THE CLSI STANDARD M22, QUALITY CONTROL FOR COMMERCIALLY PREPARED MICROBIOLOGICAL CULTURE MEDIA FOR EXPECTED ATCC PERFORMANCE. NO CORRECTIVE ACTIONS WERE REQUIRED. A CROSS FUNCTIONAL TEAM CONTINUALLY MONITORS ALL PRODUCT COMPLAINTS FOR TRENDS AND DETERMINES IF ANY ADDITIONAL ACTIONS ARE NECESSARY BEYOND THE CURRENT INVESTIGATION PROCESS.

Description of Event or Problem · 0

REPORT 1 OF 2. IT WAS REPORTED AFTER USING BD BACTEC¿ PLUS AEROBIC/F CULTURE VIALS (PLASTIC) A. VARIABILIS WAS ISOLATED IN ONE PATIENT. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

Description of Event or Problem · 0

REPORT 1 OF 2. IT WAS REPORTED AFTER USING BD BACTEC¿ PLUS AEROBIC/F CULTURE VIALS (PLASTIC) A. VARIABILIS WAS ISOLATED IN ONE PATIENT. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
75159 BD BACTEC¿ PLUS AEROBIC/F CULTURE VIALS (PLASTIC) SYSTEM, BLOOD CULTURING MDB BECTON DICKINSON CARIBE LTD. 4319541 00382904420239

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown